tryptophan has been researched along with End Stage Liver Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aji, T; Apaer, S; Li, T; Payiziwula, J; Shao, YM; Tuxun, T; Wen, H; Zhao, JM | 1 |
1 other study(ies) available for tryptophan and End Stage Liver Disease
Article | Year |
---|---|
Compared efficacy of University of Wisconsin and histidine-tryptophan-ketoglutarate solutions in ex-situ liver resection and autotransplantation for end-stage hepatic alveolar echinococcosis patients.
Topics: Adult; Autografts; Echinococcosis, Hepatic; End Stage Liver Disease; Female; Graft Survival; Hepatectomy; Histidine; Humans; Ketoglutaric Acids; Liver Transplantation; Male; Middle Aged; Organ Preservation Solutions; Postoperative Complications; Retrospective Studies; Survival Rate; Transplantation, Autologous; Tryptophan; Universities; Wisconsin; Young Adult | 2019 |